These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19916990)

  • 1. The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial.
    Dawson J; Quinn TJ; Harrow C; Lees KR; Walters MR
    Br J Clin Pharmacol; 2009 Nov; 68(5):662-8. PubMed ID: 19916990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial.
    Muir SW; Harrow C; Dawson J; Lees KR; Weir CJ; Sattar N; Walters MR
    Stroke; 2008 Dec; 39(12):3303-7. PubMed ID: 18845806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones.
    Goldfarb DS; MacDonald PA; Gunawardhana L; Chefo S; McLean L
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1960-7. PubMed ID: 23929928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol treatment reduces arterial wave reflection in stroke survivors.
    Khan F; George J; Wong K; McSwiggan S; Struthers AD; Belch JJ
    Cardiovasc Ther; 2008; 26(4):247-52. PubMed ID: 19035875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
    Doehner W; Schoene N; Rauchhaus M; Leyva-Leon F; Pavitt DV; Reaveley DA; Schuler G; Coats AJ; Anker SD; Hambrecht R
    Circulation; 2002 Jun; 105(22):2619-24. PubMed ID: 12045167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients.
    Dogan A; Yarlioglues M; Kaya MG; Karadag Z; Dogan S; Ardic I; Dogdu O; Kilinc Y; Zencir C; Akpek M; Ozdogru I; Oguzhan A; Kalay N
    Blood Press; 2011 Jun; 20(3):182-7. PubMed ID: 21133824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Xanthine Oxidase Inhibitors in Patients with History of Stroke: A Systematic Review.
    Britnell SR; Chillari KA; Brown JN
    Curr Vasc Pharmacol; 2018; 16(6):583-588. PubMed ID: 28933307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.
    Feig DI; Soletsky B; Johnson RJ
    JAMA; 2008 Aug; 300(8):924-32. PubMed ID: 18728266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
    Doria A; Galecki AT; Spino C; Pop-Busui R; Cherney DZ; Lingvay I; Parsa A; Rossing P; Sigal RJ; Afkarian M; Aronson R; Caramori ML; Crandall JP; de Boer IH; Elliott TG; Goldfine AB; Haw JS; Hirsch IB; Karger AB; Maahs DM; McGill JB; Molitch ME; Perkins BA; Polsky S; Pragnell M; Robiner WN; Rosas SE; Senior P; Tuttle KR; Umpierrez GE; Wallia A; Weinstock RS; Wu C; Mauer M;
    N Engl J Med; 2020 Jun; 382(26):2493-2503. PubMed ID: 32579810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Allopurinol on the Progression of Chronic Kidney Disease.
    Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; de Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW;
    N Engl J Med; 2020 Jun; 382(26):2504-2513. PubMed ID: 32579811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
    Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
    N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.
    Sakuma M; Toyoda S; Arikawa T; Koyabu Y; Kato T; Adachi T; Suwa H; Narita JI; Anraku K; Ishimura K; Yamauchi F; Sato Y; Inoue T;
    Clin Exp Nephrol; 2018 Dec; 22(6):1379-1386. PubMed ID: 29916098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopurinol improves endothelial dysfunction in chronic heart failure.
    Farquharson CA; Butler R; Hill A; Belch JJ; Struthers AD
    Circulation; 2002 Jul; 106(2):221-6. PubMed ID: 12105162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial.
    Higgins P; Walters MR; Murray HM; McArthur K; McConnachie A; Lees KR; Dawson J
    Heart; 2014 Jul; 100(14):1085-92. PubMed ID: 24790069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial.
    Gaffo AL; Calhoun DA; Rahn EJ; Oparil S; Li P; Dudenbostel T; Feig DI; Redden DT; Muntner P; Foster PJ; Biggers-Clark SR; Mudano A; Sattui SE; Saddekni MB; Bridges SL; Saag KG
    Arthritis Rheumatol; 2021 Aug; 73(8):1514-1522. PubMed ID: 33779064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol therapy improves vascular endothelial function in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials.
    Xin W; Mi S; Lin Z
    Cardiovasc Ther; 2016 Dec; 34(6):441-449. PubMed ID: 27542348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.